Sarah Cannon Docs
@SarahCannonDocs
Followers
4K
Following
7K
Media
1K
Statuses
6K
A leading oncology research organization conducting community-based clinical trials.
Nashville, TN
Joined May 2013
SCRI is transforming cancer care through groundbreaking trials at 250 locations in 24 states. Join us in advancing therapies and offering hope. Watch how we collaborate to make a difference. #CancerResearch #ClinicalTrials #NewHope #SCRI
https://t.co/zphcVMRbmh
0
1
3
Sarah Cannon Research Institute will present 100 abstracts at #ASH25, marking our largest presence yet. 50+ investigators will share breakthroughs in blood cancers & disorders. Learn more: https://t.co/ExEh830ZRr
0
0
0
Mike’s cancer journey shows the power of research + compassionate care. At SCRI, he found hope through clinical trials and unwavering support. Watch his story: https://t.co/L2OokvGxUh
#CancerCare #ClinicalTrials #PatientStories
@McKesson | @SCRIOncology
0
0
0
Big news from #ESMO25! Dr. @ErikaHamilton9 discusses DESTINY-Breast11 & 05 trials showing T-DXd moves into curative settings for HER2+ breast cancer. ✅ 83% pCR rate ✅ Anthracycline-sparing approach https://t.co/EpyboM1rjo
#Oncology #BreastCancer #ClinicalTrials
medpagetoday.com
0
2
6
We’re expanding our collaboration with @bmsnews to accelerate cancer research and broaden access to clinical trials through SCRI’s Accelero model. #CancerResearch
https://t.co/q4i7BVB4c2
0
0
1
November is #LungCancerAwarenessMonth. Dr. @MLJohnsonMD2 of @SCRIOncology spoke with @NC5 about how early detection and clinical trials are changing the future of lung cancer care. From low-dose CT scans to bispecifics — hope is here. 📺 Watch: https://t.co/quZpglputb
#Oncology
0
0
1
⭐️Incredible start to the morning at the Target Cancer Foundation meeting! @targetcancer #TCF25 🎯 Dr. @AndreaCercek delivered an amazing talk on neoadjuvant tumor agnostic immunotherapy !!! 100 % response in Rectal cancer @Dr_R_Kurzrock took us on a journey to the top of Mt.
0
9
38
New findings from the #HER2CLIMB05: Adding tucatinib to first-line maintenance therapy significantly improved PFS for patients with HER2+ metastatic #breastcancer. Read more via @CancerNetwork: https://t.co/47Foed1kXE Expert insight from @ErikaHamilton9 #Oncology
cancernetwork.com
The safety profile of tucatinib plus trastuzumab and pertuzumab was consistent with the established profiles of each individual agent.
0
1
1
Journalist Amy Robach opens up about discovering breast cancer after a filmed mammogram. SCRI’s Dr. @ErikaHamilton9 shares expert tips on risk and prevention on @DrewBarrymoreTV. Watch here: https://t.co/Sb2GXZNxOn
#BreastCancerAwareness #SCRIExperts
0
0
2
Learn about testicular cancer diagnosis, treatment options, and shared decision-making in this @cure_today segment featuring SCRI expert Dr. @BGarmezy: 🔗 https://t.co/DRpiLD4rkj
#TesticularCancer #CancerEducation #SCRI
curetoday.com
From diagnosis to treatment, here is what patients need to know about stage 1 testicular cancer.
0
1
0
PHAROS 4-year data: 50% of treatment-naïve patients with BRAF V600E–mutant NSCLC on encorafenib + binimetinib are alive at 4 years. 👏 Kudos to @MLJohnsonMD2 for driving innovation in targeted therapy! 🔗 https://t.co/l3L9kBiteK
#NSCLC #Oncology #PrecisionMedicine #SCRI
ajmc.com
A mini oral session at ESMO of targeted therapy in non-small cell lung cancer included treatments that showed effectiveness in brain metastases.
0
1
0
AI, precision medicine & collaboration are transforming oncology care. At #PCOC2025, experts like Dr. @VivekSubbiah shared how these trends will drive better outcomes for patients. Watch the video + read the article: 🔗 https://t.co/fpjrWLawne
#Oncology #AI #CancerCare
ajmc.com
Five experts share their key takeaways from Patient-Centered Oncology Care® (PCOC) 2025, highlighting AI integration and collaboration to improve care.
0
4
5
Your breast cancer risk is personal—and understanding it is powerful. @SarahCannonDocs's Dr. Denise Yardley shares how genetic testing is changing prevention on @NC5. 🎥 Watch: https://t.co/BnjAk94vfJ
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI
newschannel5.com
October is Breast Cancer Awareness Month. 1 in 8 women are diagnosed in their lifetime. It is most common in older women but can also affect younger women and men.
0
0
1
We’re celebrating Dr. Howard “Skip” Burris’s remarkable career as he prepares to retire as President & CMO of SCRI. His legacy: 850+ first-in-human trials, countless lives impacted. 💙 Welcome new leaders and read the full update: https://t.co/rmTeT1P8ug
1
1
13
At 45, Bryan was diagnosed with advanced prostate cancer. A #BRCA mutation led him to a clinical trial through #SCRI at @TexasOncology with @MikeLattanzi. Today, his PSA levels are undetectable—and he’s thriving. #ProstateCancer #SCRI #USOncologyNetwork #ClinicalTrials
0
0
3
Bill, 76, joined a clinical trial at SCRI to treat stage IV #ProstateCancer. His goal: dance at his daughter’s wedding. Now celebrating a grandchild & still practicing law—while seeing a 15% reduction in disease. Hope lives here. 🔗 https://t.co/VywdIXnEXi
#SCRI #ClinicalTrials
0
0
0
Dr. Kathleen Moore of #SCRI shares the latest on PARP inhibitors in ovarian cancer care in a new @OncLive interview. 🔗 https://t.co/ZSfjsHJe4z
#SCRI #OvarianCancer #PARPInhibitors #CancerResearch
onclive.com
Kathleen N. Moore, MD, MS, discusses the use of PARP inhibitors in patients with ovarian cancer.
0
1
2
🎧 SCRI’s Dr. Garmezy & Dr. Bupathi discuss how to optimize GU cancer care in community settings on Oncology Decoded Ep. 13 from #WorldGU2025. 🔗 https://t.co/hKmS0188oA
#SCRI #CancerResearch #GUOncology #OncologyDecoded
cancernetwork.com
Experts discuss considerations for improving the care of patients with prostate, kidney, and bladder cancer in community-based practices at World GU 2025.
0
0
0
🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #WorldGU2025 on Oncology Decoded. 🔗 https://t.co/odh0MzNFBV
#SCRI #CancerResearch #GUOncology #OncologyDecoded
cancernetwork.com
Experts highlight methods for optimally treating patients with genitourinary cancers harboring variant histologies at World GU 2025.
0
0
0
Mary is proof that hope and research go hand in hand. She’s in a clinical trial for IV #ovariancancer at #SCRI at Mary Crowley—and her disease has remained stable since March. She’s walked the Camino de Santiago, joined the Lourdes Pilgrimage, & got a tattoo to celebrate it all.
0
1
7
Dr. Hans Lee & Dr. Kris Patel from @SCRIoncology share how new therapies like CAR T-cell treatment are changing lives. 📺 Watch the full @NC5 segment here: https://t.co/9re1S73O9E
#BloodCancerAwareness #LymphomaAwareness #CancerCare #SCRI
0
1
4